BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33593696)

  • 21. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis.
    Chang X; Liu T; Zhang F; Ji C; Zhao X; Wang W; Guo H
    J Endourol; 2015 May; 29(5):518-25. PubMed ID: 25556579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncological and Functional Outcomes of Laparoscopic Radiofrequency Ablation and Partial Nephrectomy for T1a Renal Masses: A Retrospective Single-center 60 Month Follow-up Cohort Study.
    Park JM; Yang SW; Shin JH; Na YG; Song KH; Lim JS
    Urol J; 2019 Feb; 16(1):44-49. PubMed ID: 30120758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience.
    Abdelsalam ME; Awad A; Baiomy A; Irwin D; Karam JA; Matin SF; Sheth RA; Habibollahi P; Odisio BC; Lu T; Ahrar K
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes of CT-guided percutaneous cryoablation of T1a and T1b renal cell carcinoma.
    Spiliopoulos S; Marzoug A; Ra H; Arcot Ragupathy SK
    Diagn Interv Radiol; 2021 Jul; 27(4):524-528. PubMed ID: 34313238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous microwave ablation of renal masses in a UK cohort.
    John JB; Anderson M; Dutton T; Stott M; Crundwell M; Llewelyn R; Gemmell A; Bufacchi R; Spiers A; Campain N
    BJU Int; 2021 Apr; 127(4):486-494. PubMed ID: 32871034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
    Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
    AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome.
    Stern JM; Gupta A; Raman JD; Cost N; Lucas S; Lotan Y; Raj GV; Cadeddu JA
    BJU Int; 2009 Sep; 104(6):786-9. PubMed ID: 19426196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma.
    Takaki H; Yamakado K; Soga N; Arima K; Nakatsuka A; Kashima M; Uraki J; Yamada T; Takeda K; Sugimura Y
    Jpn J Radiol; 2010 Jul; 28(6):460-8. PubMed ID: 20661697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation for the treatment of small renal masses: safety and oncologic efficacy.
    Joniau S; Tsivian M; Gontero P
    Minerva Urol Nefrol; 2011 Sep; 63(3):227-36. PubMed ID: 21993321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation.
    Moreland AJ; Ziemlewicz TJ; Best SL; Hinshaw JL; Lubner MG; Alexander ML; Brace CL; Kitchin DR; Hedican SP; Nakada SY; Lee FT; Abel EJ
    J Endourol; 2014 Sep; 28(9):1046-52. PubMed ID: 24846329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous radiofrequency for the treatment of small renal masses: Analysis of outcomes and complications after 10 years of experience.
    Herrero Blanco E; Domínguez Esteban M; Alonso Mediavilla E; Fernández Flórez A; Lastra García-Barón P; Azueta Etxebarría A; Ballestero Diego R; Ramos Barseló E; Zubillaga Guerrero S; Velilla Díez G; Calleja Hermosa P; Varea Malo R; Fernández Guzmán E; Gutiérrez Baños JL
    Actas Urol Esp (Engl Ed); 2021 May; 45(4):273-280. PubMed ID: 33541744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of CT-guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney.
    Meng H; Yang H; Jia H; Pan F; Dong X; Liu B; Li C
    Int J Hyperthermia; 2021; 38(1):691-695. PubMed ID: 33899668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Significance of Advanced Age in Patients with T1a Renal Cell Carcinoma Treated by Microwave Ablation: A 16-Year Experience.
    Hou Q; Wang Y; Zhang D; Luo Y; Dong L; Mu M; Yu J; Liang P
    Technol Cancer Res Treat; 2023; 22():15330338231183585. PubMed ID: 38018134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of radiofrequency on small renal masses: Complications, effects on renal fonction and oncological outcomes].
    Laquet P; Pradère B; Francois M; Ravel A; Lambert C; Guy L
    Prog Urol; 2022 Jul; 32(8-9):551-557. PubMed ID: 35577669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.